Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Henkel AG and Co KGaA | 95 |
| 2 | Toyobo Co Ltd | 64 |
| 3 | Dow Inc | 57 |
| 4 | Ajinomoto Co Inc | 34 |
| 5 | Chevron Phillips Chemical Co LLC | 34 |
| 6 | Novartis AG | 29 |
| 7 | Berkshire Hathaway Inc | 28 |
| 8 | British American Tobacco PLC | 27 |
| 9 | Cohbar Inc | 22 |
| 10 | Bayer AG | 21 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | A61K | Medicinal preparations | 450 |
| 2 | C07D | Heterocyclic compounds | 425 |
| 3 | A61P | Therapeutic activity (drug indications) | 396 |
| 4 | C07C | Acyclic and carbocyclic compounds | 243 |
| 5 | C12P | Fermentation, enzyme processes | 238 |
| 6 | C12N | Microorganisms, enzymes | 208 |
| 7 | C08G | Polymers from non-vinyl bonds (e.g. polyamides, polyesters) | 197 |
| 8 | A61Q | Cosmetics, personal care | 164 |
| 9 | G01N | Investigating / analysing materials | 94 |
| 10 | C12Y | Enzyme nomenclature (EC numbers) | 88 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionRepresentative patents
The filings that best characterise the patent activity around this compound, most-referenced first.
| Title | Year | Assignee | Cited by |
|---|---|---|---|
| Use of 3-amino-4-hydroxybenzoic acid for the treatment of retroviral infections | 2001 | 8 | |
| Preparation of 3-amino-4-hydroxybenzoic acids | 1986 | Dow Inc | 5 |
| Preparation of 3-amino-4-hydroxybenzoic acids | 1989 | Toyobo Co Ltd | 4 |
| PREPARATION OF 3-AMINO-4-HYDROXYBENZOIC ACIDS | 1989 | Dow Inc | 2 |
| Escherichia coli capable of producing 3-amino-4-hydroxybenzoic acid | 2017 | Ajinomoto Co Inc | 1 |
How research activity has moved
Papers published per year for this compound, over the last decade of indexed records.
| Year | Papers |
|---|---|
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
Who's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | Yasuo Ohnishi | The University of Tokyo | 9 |
| 2 | Sueharu Horinouchi | The University of Tokyo | 5 |
| 3 | Hirokazu Suzuki | The University of Tokyo | 3 |
| 4 | Hideo Kawaguchi | Kobe University | 3 |
| 5 | Chiaki Ogino | Kobe University | 3 |
| 6 | Yoshinori Sugai | The University of Tokyo | 3 |
| 7 | Yohei Katsuyama | The University of Tokyo | 3 |
| 8 | Akihiko Kondo | Kobe University | 3 |
| 9 | Kouji Uematsu | Kobe University | 2 |
| 10 | Heinz G. Floss | University of Washington | 2 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| A nitrous acid biosynthetic pathway for diazo group formation in bacteria | 2015 | 132 | Microbial Natural Products and Biosynthesis |
| Effect of vanillic acid on COQ6 mutants identified in patients with coenzyme Q10 deficiency | 2013 | 76 | Advanced battery technologies research |
| Biochemical and Genetic Insights into Asukamycin Biosynthesis | 2010 | 67 | Microbial Natural Products and Biosynthesis |
| Interaction of mushroom tyrosinase with aromatic amines, o-diamines and o-aminophenols | 2004 | 52 | Phytochemicals and Antioxidant Activities |
| Kinetic and Chemical Mechanism of ArylamineN-Acetyltransferase fromMycobacterium tuberculosis | 2008 | 42 | Tuberculosis Research and Epidemiology |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the chemical composition and molecular weight of Cheetan?
Which organizations hold the largest patent portfolios for this compound?
What patent and publication activity has been recorded for this compound?
What are the primary technical domains associated with patents for this compound?
What specific uses of this compound have been documented in patents?